Systematic review / meta-analysis / 2020
EPA/DHA supplementation reduced triglycerides and increased HDL, LDL, and total cholesterol compared with ALA supplementation.
A meta-analysis of 14 randomized controlled trials with 1,137 participants compared the effects of EPA/DHA versus ALA supplementation on cardiometabolic outcomes. Compared with ALA, EPA/DHA supplementation resulted in a greater reduction in triglycerides (WMD -0.191 mmol l-1; 95% CI -0.249, -0.133), but greater increases in HDL (WMD 0.033 mmol l-1; 95% CI 0.004, 0.062), LDL (WMD 0.130 mmol l-1; 95% CI 0.006, 0.253), and total cholesterol (WMD 0.179 mmol l-1; 95% CI 0.006, 0.352). When administered separately, modest HDL increases were observed with DHA supplementation (0.161 mmol l-1; 95% CI 0.017, 0.304), but not with EPA (0.040 mmol l-1; 95% CI -0.132, 0.212).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 1,137 participants across 14 RCTs
- What was measured
- Cardiometabolic risk factors including triglycerides, HDL, LDL, and total cholesterol
THE PAPER
Effects of eicosapentaenoic acid and docosahexaenoic acid versus α-linolenic acid supplementation on cardiometabolic risk factors: a meta-analysis of randomized controlled trials.
Chen H, Deng G, Zhou Q, Chu X, Su M, Wei Y, Li L, Zhang Z. Food Funct, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.